Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
about
Long-term nitrite inhalant exposure and cancer risk in MSM.Current knowledge on HIV-associated Plasmablastic Lymphoma.Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphomaAre patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis.Bronchopulmonary Kaposi's sarcoma.Optimal management of cervical cancer in HIV-positive patients: a systematic review.Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey.Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma.Bilateral Chest X-Ray Shadowing and Bilateral leg lesions - A case of Pulmonary Kaposi Sarcoma.A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety.HIV-associated hematologic malignancies: Experience from a Tertiary Cancer Center in India.Haematological manifestations of human immune deficiency virus infection.Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes.Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis.Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.Squamous Cell Cancer of Unknown Primary and Primary Breast Cancer in an HIV-Infected Woman: The Importance of Cancer Screening for People Living with HIV/AIDS.Role of Feline Immunodeficiency Virus in Lymphomagenesis--Going Alone or Colluding?Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literatureA natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.Severe Kaposi Sarcoma in an Urban Public Hospital.Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.End-of-life care for HIV-infected patients with malignancies: A questionnaire-based survey.Ocular Kaposi's sarcoma as the first manifestation of HIV infection.The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT.Infection: a Cause of and Cure for Cancer.Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation.Malignancies in HIV-Infected and AIDS Patients.Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.Ageing with HIV.Study of Natural Cytotoxicity Receptors in Patients with HIV/AIDS and Cancer: A Cross-Sectional Study.MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study.Recent advances in cancer outcomes in HIV-positive smokers.International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK
P2860
Q33631041-2EEC6AC1-1CA3-408B-B2DD-24A492A01FDAQ34531971-8476B2AC-7A62-46C0-82C2-F96BEF22566AQ35511780-C8A39ECB-C7FA-4C27-B71D-FB059816C709Q35690978-F9C20D0E-C60C-419C-8F20-5532242225A7Q35849621-DF1C13F9-EE69-406E-9CAB-17B9F085DAE8Q36051789-13F26114-5EEE-4FF3-9470-ACEB6F1662E5Q36083124-F7093894-F94C-4A6C-B79A-340BB7A1EAE9Q36399193-F8C46749-BB4F-44A7-899F-2BFF293E8A9EQ36781293-40CE83ED-386C-4FC7-BC9D-680478B5C265Q36935830-FF76A32D-3340-4EBA-A12B-783EC310ABC0Q37147418-A74EC8E4-573F-45AE-A052-9E357A69F213Q37265098-A1F4940B-F1DA-4FAB-B918-E45FAE357138Q38603109-19E34BAC-6E07-4836-B927-EF0E8E749F9CQ38665860-EF035213-2160-48B0-8184-E3152AB7FE87Q38673151-A9FB24EF-6C08-4F2F-977A-5A560881AFDAQ38673536-2E5B0D48-6698-4F55-841C-3631261E1079Q38728570-BAD9C06A-5C02-4CC8-B69C-81F32F5EE657Q38795312-270D24A7-A1ED-44F2-A2B8-A3F5EB552F0DQ38795372-A44B0506-5FC8-4AC9-819D-3098869354A3Q38907078-3AE71F75-CE56-469F-8187-EDB661C858DBQ39064390-597ED31F-F6AA-479F-A910-9E1B5C7CDE20Q39508906-363DA118-C351-4CE5-894D-CB0775B1DDFEQ39953766-819E1388-4ADA-4C68-A180-82530A22F4B5Q40230391-E2AD1E8F-DE73-40BB-B7D1-8428D8CAD299Q40233429-AFA6EA7F-043E-4D8C-8DBE-63EA10750718Q40675626-FFAB8A28-1303-47F4-BE2F-80C8C452E976Q40701232-85D06ABD-EBD5-41EF-A65D-4F8BA5CFD89FQ41055765-66F07757-3BB7-4FEE-85F9-D602EDADC352Q41930803-727AC2E2-5713-4610-8A30-91C24B4790EEQ43949036-435DA2AE-8AAD-4D64-B557-96188EB8E1B5Q47142729-7A4EBB74-4E8E-4D7A-9854-90F94E17192CQ47597201-7F6B849B-A90B-4CCA-B1BF-EE946D996707Q47886730-118CE3F6-6384-437A-BAE1-50FC29F7797DQ48528597-017CDF33-C46D-42EE-8DEA-0EC80116B282Q50001938-6EB129D6-06D4-485D-B945-67C6B308172EQ51660836-7627F8A7-D5EB-4D0F-AD5F-874BBDF4ECF0Q51732134-A06699CF-C95B-4A93-9D3B-E0F7EC473C69Q53068032-824A21EC-82FE-4C2E-B5A7-6E670D109C5DQ55266710-73FCEC51-3245-42A5-B2D7-A316A5614C35Q56762706-642BED0E-8554-4203-ACEB-A7C6BD252088
P2860
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
@ast
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
@en
type
label
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
@ast
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
@en
prefLabel
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
@ast
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
@en
P2860
P1433
P1476
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
@en
P2093
David M Aboulafia
P2860
P304
P356
10.1097/QAD.0000000000000071
P407
P577
2014-02-01T00:00:00Z